Skip to content
VuFind
  • Login
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Advanced
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
Cover Image

Saved in:
Bibliographic Details
Main Authors: Francesco Pignatti, Filip Josephson, Pierre Demolis, Olli Tenhunen, Elias Péan, Douwe Postmus
Format: Artículo Open Access
Published: Wiley 2025
Subjects:
Clinical Pharmacology & Therapeutics
Online Access:https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.3708
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Holdings
  • Description
  • Table of Contents
  • Comments
  • Similar Items
  • Staff View

Internet

https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.3708

Similar Items

  • Clinical Benefit, Trials, and Regulatory Approval of Oncology Indications Under Multiple Expedited Programs for Drug Marketing in China, 2018–2024
    by: Jie Zhang, et al.
    Published: (2025)
  • Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real‐World Data
    by: Francesco Pignatti, et al.
    Published: (2026)
  • Use of FDA Expedited Programs and Development Timelines for New Molecular Entity Drug and New Biologic Approvals by Sponsor Experience
    by: Kanhai S. Amin, et al.
    Published: (2025)
  • Dosage Optimization: A Regulatory Perspective for Developing Oncology Drugs
    by: Atiqur Rahman, et al.
    Published: (2024)
  • Clinical Pharmacology Characterization of Bispecific T‐Cell Engagers: A Summary Based on FDA Approvals
    by: Ting Wang, et al.
    Published: (2025)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs